Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura

Internal Medicine Journal

Volumn 42, Issue 3, 2012, Pages

  Child, N ^a   O'Carroll, M ^a   Berkahn, L ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

ITP; Monoclonal antibody; Therapy

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; IMMUNOGLOBULIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADL DISABILITY; AGED; ARTICLE; CASE REPORT; COUGHING; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRY COUGH; DYSPNEA; EXERCISE TOLERANCE; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTERSTITIAL LUNG DISEASE; LUNG CAPACITY; LUNG CARBON MONOXIDE DIFFUSION CAPACITY; LUNG FIBROSIS; MALE; NONHUMAN; OXYGEN SATURATION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTOSIS; PRIORITY JOURNAL; SINGLE DRUG DOSE; STEROID THERAPY; THROMBOCYTOPENIA; TOTAL LUNG CAPACITY;

AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AZATHIOPRINE; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; HEMORRHAGE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MALE; PNEUMONIA, PNEUMOCYSTIS; PREDNISONE; PULMONARY FIBROSIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TOMOGRAPHY, X-RAY COMPUTED; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VINCRISTINE;

EID: 84858728192     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2011.02701.x     Document Type: Article

References (13)

1. George J, Woolf S, Raskob GE, Wasser JS, Aledort LM, Ballem PJ etal. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Haematology. Blood 1996; 88:3-40.
2. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children, and pregnancy. Br J Haematol 2003; 120: 574-96.
3. Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C etal. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 2007; 146: 25-44.
4. Godeau B, Provan D, Bussel J. Immune thrombocytopenic purpura in adults. Curr Opin Hematol 2007; 14: 535-56.
5. Provan D etal. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168-86.
6. Gigliotti F, Wright T. Immunopathogenesis of Pneumocystis carinii pneumonia. Expert Rev Mol Med 2005; 7: 1-16.
7. Suffredini AF, Owens GR, Tobin MJ, Slasky BS, Peel RL, Costa F. Long-term prognosis of survivors of Pneumocystis carinii pneumonia. Sturctural and functional correlates. Chest 1986; 89: 229-33.
8. Medeot M, Zaja F, Vianelli N, Battista M, Baccarani M, Patriarca F etal. Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow up results. Eur J Haematol 2008; 81: 165-9.
9. Wagner SA, Mehta AC, Laber DA. Rituximab induced interstitial lung disease. Am J Hematol 2007; 82: 916-19.
10. Swords R, Power D, Fay M, O'Donnell R, Murphy PT. Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP). Am J Hematol 2004; 77: 103-4.
11. Liu S, Hong XN, Gu YJ, Wang BY, Luo AG, Cao J. Interstitial pneumonitis during rituximab containing chemotherapy for non-Hodgkin lymphoma. Leuk Lymphoma 2008; 49: 1778-83.
12. Ennishi D, Terui Y, Yokoyama M, Mishima Y, Takahashi S, Takeuchi K etal. Increased incidence of interstitial pneumonia by CHOP combined with rituximab. Int J Hematol 2008; 87: 393-7.
13. Burton C, Kaczmarski R, Jan-Mohamed R. Interstitial pneumonitis related to rituximab therapy. N Engl J Med 2003; 348: 2690-91.